Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 1/2019

01-01-2019 | Review Article

Are electronic cigarettes a healthier alternative to conventional tobacco smoking?

Authors: Jan Löhler, Barbara Wollenberg

Published in: European Archives of Oto-Rhino-Laryngology | Issue 1/2019

Login to get access

Abstract

Electronic cigarettes (EC) with and without nicotine are used by more and more consumers within the last decade. The long-term risks of vapor inhalation are unknown. This study should describe the state of the art of knowledge with respect to the following four items: (1) ingredients of the vapor and their potential risks, the influence of EC on smoking of combustible tobacco to (2) adults and (3) the youth, and (4) the side effects of passive vaping. The vapor of EC contains, in comparison to tobacco smoke, less harmful substances, qualitatively and quantitatively. But, due to failing standardization of EC, this comparison is difficult. Adults are often using both, EC and combustible cigarettes dually. In addition, EC were used for supporting smoke-quitting. Unfortunately, consuming EC with and without nicotine due later to a higher risk of conventional tobacco smoking for the user. In general, the effects of passive vaporing are unknown. Although the vapor of EC is less harmful than tobacco smoke, EC are not hazard-free lifestyle products. Technical standardization should be desirable. Adult smoker’s benefit using EC is given by completely change to EC only. The rates of success using EC for smoke quitting are not well evaluated. Children and their parents should be informed on the risks of EC use as a precursor of combustible smoking mandatorily. Internet selling EC to any non-adult should be forbidden by law. EC ought not to be allowed to weaken non-smoker’s rights, and third persons should be protected by the potential hazards of EC vaporing.
Literature
2.
go back to reference Falgairolle E (1897) Jean Nicot, ambassadeur de France en Portugal au XVIème siècle. Paris Falgairolle E (1897) Jean Nicot, ambassadeur de France en Portugal au XVIème siècle. Paris
3.
go back to reference Gregorii JG (1708) (Melissantes) Geographia Novissima, Teil 1, Frankfurt, Leipzig und Erfurt, S. 1.181 Gregorii JG (1708) (Melissantes) Geographia Novissima, Teil 1, Frankfurt, Leipzig und Erfurt, S. 1.181
4.
go back to reference Zeissler K (1993) Die “Langen Kerls”. Geschichte des Leib- und Garderegiments Friedrich Wilhelms I. Ullstein, Frankfurt am Main u. a. Zeissler K (1993) Die “Langen Kerls”. Geschichte des Leib- und Garderegiments Friedrich Wilhelms I. Ullstein, Frankfurt am Main u. a.
5.
go back to reference Spode H (2010) Kulturgeschichte des Tabaks. In: Singer M (eds) Alkohol und Tabak. Grundlagen und Folgeerkrankungen. Thieme, Stuttgart Spode H (2010) Kulturgeschichte des Tabaks. In: Singer M (eds) Alkohol und Tabak. Grundlagen und Folgeerkrankungen. Thieme, Stuttgart
6.
go back to reference Müller FH (1940) Tabakmißbrauch und Lungencarcinom. Zeitschrift für Krebsforschung 49:57CrossRef Müller FH (1940) Tabakmißbrauch und Lungencarcinom. Zeitschrift für Krebsforschung 49:57CrossRef
7.
go back to reference Albrecht J (2018) Als die Welt im Fieber lag. Frankfurter Allg. Sonntagszeitung, Nr. 9, S. 59–62 Albrecht J (2018) Als die Welt im Fieber lag. Frankfurter Allg. Sonntagszeitung, Nr. 9, S. 59–62
8.
go back to reference Lickint F (1929) Tabak und Tabakrauch als ätiologischer Faktor des Carcinoms. Zeitschrift für Krebsforschung 30:349–365CrossRef Lickint F (1929) Tabak und Tabakrauch als ätiologischer Faktor des Carcinoms. Zeitschrift für Krebsforschung 30:349–365CrossRef
9.
go back to reference Proctor RN (1999) Why did the Nazis have the world’s most aggressive anti-cancer campaign? Endeavour 23(2):76–79CrossRefPubMed Proctor RN (1999) Why did the Nazis have the world’s most aggressive anti-cancer campaign? Endeavour 23(2):76–79CrossRefPubMed
10.
12.
go back to reference Terry LL (1964) Smoking and health: report of the advisory committee to the surgeon general of the United States. U-23 Department of Health, Education, and Welfare. Public Health Service Publication No. 1103, Bethesda Terry LL (1964) Smoking and health: report of the advisory committee to the surgeon general of the United States. U-23 Department of Health, Education, and Welfare. Public Health Service Publication No. 1103, Bethesda
14.
15.
go back to reference Robinson J (1927) Patent “Electric vaporizers”. US 1775947 A Robinson J (1927) Patent “Electric vaporizers”. US 1775947 A
16.
go back to reference Gilbert H (1963) Patent “Smokeless non-tobacco cigarette”. US 3200819 A Gilbert H (1963) Patent “Smokeless non-tobacco cigarette”. US 3200819 A
17.
go back to reference Horning L (2016) Die Geschichte der E-Zigarette. In: Die E-Zigarette, Geschichte—Gebrauch—Kontroverse. Stöver H (Hrsg.), Fachhochschulverlag, Frankfurt/ M Horning L (2016) Die Geschichte der E-Zigarette. In: Die E-Zigarette, Geschichte—Gebrauch—Kontroverse. Stöver H (Hrsg.), Fachhochschulverlag, Frankfurt/ M
20.
go back to reference Bundesgesetzblatt (2016) Teil I, Nr. 15, Bl. 569 ff Bundesgesetzblatt (2016) Teil I, Nr. 15, Bl. 569 ff
21.
go back to reference Henkler F, Tkachenko A, Paschke M, Hutzler C, Luch A (2016) Gesundheitliche Risiken von E-Zigaretten. In: Stöver H (Hrsg) Die E-Zigarette, Geschichte—Gebrauch—Kontroverse. Fachhochschulverlag, Frankfurt/M Henkler F, Tkachenko A, Paschke M, Hutzler C, Luch A (2016) Gesundheitliche Risiken von E-Zigaretten. In: Stöver H (Hrsg) Die E-Zigarette, Geschichte—Gebrauch—Kontroverse. Fachhochschulverlag, Frankfurt/M
23.
go back to reference Jazbinsek D (2016) Gewinnmaximierung durch Schadensreduzierung? In: Stöver H (Hrsg) Die E-Zigarette, Geschichte—Gebrauch—Kontroverse. Fachhochschulverlag, Frankfurt/M Jazbinsek D (2016) Gewinnmaximierung durch Schadensreduzierung? In: Stöver H (Hrsg) Die E-Zigarette, Geschichte—Gebrauch—Kontroverse. Fachhochschulverlag, Frankfurt/M
29.
go back to reference Kotz D, Böckmann M, Kastaun S (2018) the use of tobacco, E-cigarettes, and methods to quit smoking in Germany. A representative study using 6 waves of data over 12 months (the DEBRA study). Dtsch Arztebl Int 115:235–242PubMedPubMedCentral Kotz D, Böckmann M, Kastaun S (2018) the use of tobacco, E-cigarettes, and methods to quit smoking in Germany. A representative study using 6 waves of data over 12 months (the DEBRA study). Dtsch Arztebl Int 115:235–242PubMedPubMedCentral
30.
go back to reference Hilliendorf A (2017) E-Shishas und E-Zigaretten, Umsätze weisen steil nach oben. Dtsch Arztebl 114:A68 Hilliendorf A (2017) E-Shishas und E-Zigaretten, Umsätze weisen steil nach oben. Dtsch Arztebl 114:A68
33.
go back to reference Stöver H (2016) Elektronische Dampfprodukte und Harm Reduction. In: Stöver H (Hrsg.) Die E-Zigarette, Geschichte—Gebrauch—Kontroverse. Fachhochschulverlag, Frankfurt/M Stöver H (2016) Elektronische Dampfprodukte und Harm Reduction. In: Stöver H (Hrsg.) Die E-Zigarette, Geschichte—Gebrauch—Kontroverse. Fachhochschulverlag, Frankfurt/M
34.
go back to reference Schaller K, Mons U (2017) E-Shishas und E-Zigaretten: debatte um Schaden und Nutzen. Dtsch Arztebl 114(3):A70 Schaller K, Mons U (2017) E-Shishas und E-Zigaretten: debatte um Schaden und Nutzen. Dtsch Arztebl 114(3):A70
35.
go back to reference Kandel D, Kandel E (2015) The gateway hypothesis of substance abuse: developmental, biological and societal perspectives. Acta Paediatr 104(2):130–137CrossRefPubMed Kandel D, Kandel E (2015) The gateway hypothesis of substance abuse: developmental, biological and societal perspectives. Acta Paediatr 104(2):130–137CrossRefPubMed
38.
go back to reference Goniewicz ML, Knysak J, Gawron M et al (2014) Levels of selected carcinogens and toxicants in vapor from electronic cigarettes. Tob Control 23:133–139CrossRefPubMed Goniewicz ML, Knysak J, Gawron M et al (2014) Levels of selected carcinogens and toxicants in vapor from electronic cigarettes. Tob Control 23:133–139CrossRefPubMed
39.
go back to reference Batra A (2011) Pharmakologische Aspekte des Nikotins. In: Singer MV, Batra A, Mann K (eds) Alkohol und Tabak. Grundlagen und Folgeerkrankungen. Thieme, Stuttgart Batra A (2011) Pharmakologische Aspekte des Nikotins. In: Singer MV, Batra A, Mann K (eds) Alkohol und Tabak. Grundlagen und Folgeerkrankungen. Thieme, Stuttgart
40.
go back to reference Haussmann H, Fariss MW (2016) Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se. Crit Rev Toxicol 46:701–734CrossRefPubMedPubMedCentral Haussmann H, Fariss MW (2016) Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se. Crit Rev Toxicol 46:701–734CrossRefPubMedPubMedCentral
41.
42.
go back to reference Knezevich A, Muzic J, Hatsukami DK, Hecht SS, Stepanov I (2013) Nornicotine nitrosation in saliva and its relation to endogenous synthesis of N′-nitrosonornicotine in humans. Nicotine Tob Res 15:591–595CrossRefPubMed Knezevich A, Muzic J, Hatsukami DK, Hecht SS, Stepanov I (2013) Nornicotine nitrosation in saliva and its relation to endogenous synthesis of N′-nitrosonornicotine in humans. Nicotine Tob Res 15:591–595CrossRefPubMed
43.
go back to reference Lisko JG, Tran H, Stanfill SB, Blount BC, Watson CH (2015) Chemical composition and evaluation of nicotine, tobacco alkaloids, pH, and selected flavors in E-cigarette cartridges and refill solutions. Nicotine Tob Res 17:1270–1278CrossRefPubMedPubMedCentral Lisko JG, Tran H, Stanfill SB, Blount BC, Watson CH (2015) Chemical composition and evaluation of nicotine, tobacco alkaloids, pH, and selected flavors in E-cigarette cartridges and refill solutions. Nicotine Tob Res 17:1270–1278CrossRefPubMedPubMedCentral
44.
go back to reference Jazbinsk D, Gießelmann K (2018) Tabakerhitzer—Streit um rauchfreie Alternative. Dtsch Arztebl 115:A130–A136 Jazbinsk D, Gießelmann K (2018) Tabakerhitzer—Streit um rauchfreie Alternative. Dtsch Arztebl 115:A130–A136
45.
go back to reference Zhu SH, Sun JY, Bonnevie E, Cummins SE, Gamst A, Yin L, Lee M (2014) Four hundred and sixty brands of e-cigarettes and counting: Implications for product regulation. Tob Control 23(Suppl 3):iii3–iii9CrossRefPubMedPubMedCentral Zhu SH, Sun JY, Bonnevie E, Cummins SE, Gamst A, Yin L, Lee M (2014) Four hundred and sixty brands of e-cigarettes and counting: Implications for product regulation. Tob Control 23(Suppl 3):iii3–iii9CrossRefPubMedPubMedCentral
46.
go back to reference Barrington-Trimis JL, Urman R, Leventhal AM, Gauderman WJ, Cruz TB, Gilreath TD, Howland S, Unger JB, Berhane K, Samet JM, McConnell R (2016) E cigarettes, cigarettes, and the prevalence of adolescent tobacco use. Pediatrics 138(2):e20153983CrossRefPubMedPubMedCentral Barrington-Trimis JL, Urman R, Leventhal AM, Gauderman WJ, Cruz TB, Gilreath TD, Howland S, Unger JB, Berhane K, Samet JM, McConnell R (2016) E cigarettes, cigarettes, and the prevalence of adolescent tobacco use. Pediatrics 138(2):e20153983CrossRefPubMedPubMedCentral
47.
go back to reference Kreiss K (2017) Recognizing occupational effects of diacetyl: What can we learn from this history? Toxicol 388:48–54CrossRef Kreiss K (2017) Recognizing occupational effects of diacetyl: What can we learn from this history? Toxicol 388:48–54CrossRef
48.
go back to reference Behar RZ, Luov W, Lin SC, Wang Y, Valle J, Pankow JF, Talbot P (2017) Distribution, quantification and toxicity of cinnamaldehyde in electronic cigarette refill fluids and aerosols. Tob Control 25(Suppl 2):ii94–ii102CrossRef Behar RZ, Luov W, Lin SC, Wang Y, Valle J, Pankow JF, Talbot P (2017) Distribution, quantification and toxicity of cinnamaldehyde in electronic cigarette refill fluids and aerosols. Tob Control 25(Suppl 2):ii94–ii102CrossRef
49.
go back to reference Kosmider L, Sobczak A, Prokopowicz A, Kurek J, Zaciera M, Knysak J, Smith D, Goniewicz ML (2017) Cherry-flavored electronic cigarettes expose users to the inhalation irritant, benzaldehyde. Thorax 71(4):376–377CrossRef Kosmider L, Sobczak A, Prokopowicz A, Kurek J, Zaciera M, Knysak J, Smith D, Goniewicz ML (2017) Cherry-flavored electronic cigarettes expose users to the inhalation irritant, benzaldehyde. Thorax 71(4):376–377CrossRef
51.
go back to reference Schneider S, Göring T, Herr R, Herth FJ, Bauer-Kemény C, Huerkamp R, Diehl K (2016) Die E-Zigarette—Verbreitung, Konsummuster und Nutzermotive bei Siebt- und Achtklässlern. Sucht 62:153–162CrossRef Schneider S, Göring T, Herr R, Herth FJ, Bauer-Kemény C, Huerkamp R, Diehl K (2016) Die E-Zigarette—Verbreitung, Konsummuster und Nutzermotive bei Siebt- und Achtklässlern. Sucht 62:153–162CrossRef
52.
go back to reference Werse B, Müller D, Stöver H, ichtl A, Graf N (2017) Der Konsum von elektronischen Dampferzeugnissen unter Jugendlichen—Konsummuster in einer repräsentativen Stichprobe aus Frankfurt/ Main. Sucht 18:1–6 Werse B, Müller D, Stöver H, ichtl A, Graf N (2017) Der Konsum von elektronischen Dampferzeugnissen unter Jugendlichen—Konsummuster in einer repräsentativen Stichprobe aus Frankfurt/ Main. Sucht 18:1–6
53.
go back to reference Morgenstern M, Nies A, Goecke M, Hanewinkel R (2018) E-Cigarettes and the use of conventional cigarettes. A cohort study in 10th grade students in Germany. Dtsch Arztebl Int 115:243–248PubMedPubMedCentral Morgenstern M, Nies A, Goecke M, Hanewinkel R (2018) E-Cigarettes and the use of conventional cigarettes. A cohort study in 10th grade students in Germany. Dtsch Arztebl Int 115:243–248PubMedPubMedCentral
56.
go back to reference Schraufnagel DE, Blasi F, Drummond FB, Lam DCL, Latif E, Rosen MJ, Sansores R et al (2014) Electronic cigarettes. A position statement of the international forum of respiratory societies. Am J Resp Crit Care Med 190:611–618CrossRefPubMed Schraufnagel DE, Blasi F, Drummond FB, Lam DCL, Latif E, Rosen MJ, Sansores R et al (2014) Electronic cigarettes. A position statement of the international forum of respiratory societies. Am J Resp Crit Care Med 190:611–618CrossRefPubMed
57.
go back to reference Nowak D, Gohlke H, Hering T, Herth FJF, Jany B, Raupach T, Welte T, Loddenkämper R (2015) Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP) zur E-Zigarette. Pneumologie 69:131–134CrossRefPubMed Nowak D, Gohlke H, Hering T, Herth FJF, Jany B, Raupach T, Welte T, Loddenkämper R (2015) Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP) zur E-Zigarette. Pneumologie 69:131–134CrossRefPubMed
59.
go back to reference Welte T (2018) Ein Déjà-vu—warum man dieselben Fehler nie zweimal machen sollte. Dtsch Arztebl 115:223–224 Welte T (2018) Ein Déjà-vu—warum man dieselben Fehler nie zweimal machen sollte. Dtsch Arztebl 115:223–224
60.
go back to reference Glasser AM, Katz L, Pearson JL, Abudayyeh H, Niaura RS, Abrams DB, Villanti AC (2017) Overview of electronic nicotine delivery systems: a systematic review. Am J Prev Med 52:e33–e66CrossRefPubMed Glasser AM, Katz L, Pearson JL, Abudayyeh H, Niaura RS, Abrams DB, Villanti AC (2017) Overview of electronic nicotine delivery systems: a systematic review. Am J Prev Med 52:e33–e66CrossRefPubMed
63.
go back to reference Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L, Tata LJ (2015) Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring. Pediatrics 135:859–867CrossRefPubMed Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L, Tata LJ (2015) Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring. Pediatrics 135:859–867CrossRefPubMed
Metadata
Title
Are electronic cigarettes a healthier alternative to conventional tobacco smoking?
Authors
Jan Löhler
Barbara Wollenberg
Publication date
01-01-2019
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 1/2019
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-018-5185-z

Other articles of this Issue 1/2019

European Archives of Oto-Rhino-Laryngology 1/2019 Go to the issue